CMOPF
Price
$83.60
Change
+$8.60 (+11.47%)
Updated
Sep 16 closing price
Capitalization
1.28B
DSNKY
Price
$22.69
Change
-$0.25 (-1.09%)
Updated
Sep 25 closing price
Capitalization
43.09B
Interact to see
Advertisement

CMOPF vs DSNKY

Header iconCMOPF vs DSNKY Comparison
Open Charts CMOPF vs DSNKYBanner chart's image
Cosmo Pharmaceuticals
Price$83.60
Change+$8.60 (+11.47%)
Volume$100
Capitalization1.28B
Daiichi Sankyo
Price$22.69
Change-$0.25 (-1.09%)
Volume$501.3K
Capitalization43.09B
CMOPF vs DSNKY Comparison Chart in %
Loading...
CMOPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMOPF vs. DSNKY commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMOPF is a Buy and DSNKY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (CMOPF: $83.60 vs. DSNKY: $22.69)
Brand notoriety: CMOPF and DSNKY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CMOPF: 63% vs. DSNKY: 243%
Market capitalization -- CMOPF: $1.28B vs. DSNKY: $43.09B
CMOPF [@Pharmaceuticals: Major] is valued at $1.28B. DSNKY’s [@Pharmaceuticals: Major] market capitalization is $43.09B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $640.6B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMOPF’s FA Score shows that 1 FA rating(s) are green whileDSNKY’s FA Score has 1 green FA rating(s).

  • CMOPF’s FA Score: 1 green, 4 red.
  • DSNKY’s FA Score: 1 green, 4 red.
According to our system of comparison, CMOPF is a better buy in the long-term than DSNKY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMOPF’s TA Score shows that 2 TA indicator(s) are bullish while DSNKY’s TA Score has 2 bullish TA indicator(s).

  • CMOPF’s TA Score: 2 bullish, 2 bearish.
  • DSNKY’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, CMOPF is a better buy in the short-term than DSNKY.

Price Growth

CMOPF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while DSNKY (@Pharmaceuticals: Major) price change was -8.10% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.07%. For the same industry, the average monthly price growth was -0.30%, and the average quarterly price growth was +12.81%.

Industries' Descriptions

@Pharmaceuticals: Major (-1.07% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSNKY($43.1B) has a higher market cap than CMOPF($1.28B). DSNKY has higher P/E ratio than CMOPF: DSNKY (21.49) vs CMOPF (19.83). CMOPF YTD gains are higher at: 24.916 vs. DSNKY (-16.856). DSNKY has higher annual earnings (EBITDA): 405B vs. CMOPF (84.7M). DSNKY has more cash in the bank: 848B vs. CMOPF (127M). CMOPF has less debt than DSNKY: CMOPF (2.7M) vs DSNKY (102B). DSNKY has higher revenues than CMOPF: DSNKY (1.76T) vs CMOPF (182M).
CMOPFDSNKYCMOPF / DSNKY
Capitalization1.28B43.1B3%
EBITDA84.7M405B0%
Gain YTD24.916-16.856-148%
P/E Ratio19.8321.4992%
Revenue182M1.76T0%
Total Cash127M848B0%
Total Debt2.7M102B0%
FUNDAMENTALS RATINGS
CMOPF vs DSNKY: Fundamental Ratings
CMOPF
DSNKY
OUTLOOK RATING
1..100
4653
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
83
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
613
PRICE GROWTH RATING
1..100
4480
P/E GROWTH RATING
1..100
4792
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMOPF's Valuation (18) in the null industry is somewhat better than the same rating for DSNKY (83). This means that CMOPF’s stock grew somewhat faster than DSNKY’s over the last 12 months.

CMOPF's Profit vs Risk Rating (100) in the null industry is in the same range as DSNKY (100). This means that CMOPF’s stock grew similarly to DSNKY’s over the last 12 months.

DSNKY's SMR Rating (3) in the null industry is somewhat better than the same rating for CMOPF (61). This means that DSNKY’s stock grew somewhat faster than CMOPF’s over the last 12 months.

CMOPF's Price Growth Rating (44) in the null industry is somewhat better than the same rating for DSNKY (80). This means that CMOPF’s stock grew somewhat faster than DSNKY’s over the last 12 months.

CMOPF's P/E Growth Rating (47) in the null industry is somewhat better than the same rating for DSNKY (92). This means that CMOPF’s stock grew somewhat faster than DSNKY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CMOPFDSNKY
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
14%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
22%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
24%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
26%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
71%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
73%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
6%
Bearish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CMOPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALB84.833.25
+3.98%
Albemarle Corp
HOVNP20.63-0.06
-0.29%
Hovnanian Enterprises
LC16.64-0.06
-0.36%
LendingClub Corp
CMCO14.41-0.33
-2.24%
Columbus McKinnon Corp
GOCO4.38-0.24
-5.19%
GoHealth

CMOPF and

Correlation & Price change

A.I.dvisor tells us that CMOPF and GSK have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CMOPF and GSK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMOPF
1D Price
Change %
CMOPF100%
N/A
GSK - CMOPF
22%
Poorly correlated
-1.64%
NVS - CMOPF
21%
Poorly correlated
-0.63%
CHGCY - CMOPF
7%
Poorly correlated
-3.23%
DSNKY - CMOPF
5%
Poorly correlated
-1.09%
CSPCY - CMOPF
4%
Poorly correlated
-0.94%
More

DSNKY and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSNKY has been loosely correlated with CHGCY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if DSNKY jumps, then CHGCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSNKY
1D Price
Change %
DSNKY100%
-1.09%
CHGCY - DSNKY
38%
Loosely correlated
-3.23%
OTSKY - DSNKY
37%
Loosely correlated
-1.99%
DSKYF - DSNKY
34%
Loosely correlated
-2.30%
BIIB - DSNKY
23%
Poorly correlated
-1.45%
ALPMY - DSNKY
21%
Poorly correlated
-1.09%
More